Well Marker Bio Co., Ltd. announced that it has received KRW 18,000,000,000 in a round of funding on July 8, 2019. The transaction included participation from Cytogen, Inc. (KOSDAQ:A217330), HB Investment, Inc., NH Investment & Securities Co., Ltd. (KOSE:A005940), Suntree Investment Co., Ltd., Brick Investment Partners LLC, Orbit Partners Limited, and existing investor Mirae Asset Venture Investment Co., Ltd. (KOSDAQ:A100790).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,770 KRW | +4.16% | -1.81% | -27.74% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
11,930 KRW | -0.08% | -2.13% | 2.99B | ||
5,590 KRW | -0.36% | -2.78% | 217M | ||
1st Jan change | Capi. | |
---|---|---|
-27.74% | 159M | |
+15.30% | 3.82B | |
+2.34% | 2.33B | |
-19.52% | 2.02B | |
-20.72% | 1.67B | |
+31.45% | 1.14B | |
+21.58% | 760M | |
-9.39% | 697M | |
-21.63% | 566M | |
-1.29% | 290M |
- Stock Market
- Equities
- A217330 Stock
- News Cytogen, Inc.
- Well Marker Bio Co., Ltd. announced that it has received KRW 18 billion in funding from a group of investors